Skip to main content
. 2023 Aug 22;14:5111. doi: 10.1038/s41467-023-40814-9

Fig. 8. Schematic illustration of the preparation of CISP and CISP enhanced the tumor-targeted delivery of SR-717.

Fig. 8

PD-1 programmed death-1, PD-L1 programmed cell death-Ligand 1, SR SR-717, β-CD (2-hydroxypropyl)-β-cyclodextrin, Que Quercetin, PLGA poly(lactic-co-glycolic acid), QFN717 quercetin-ferrum nanoparticles (QFN) encapsulated SR-717, CISP low-cholesterol membrane-coated ICB agent and QFN717, nCISP normal-Cholesterol membrane-coated ICB agent and QFN717, C3 complement 3, CR complement receptor, IFN-I type I interferon.